QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.

Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.

Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma,  modelling experts, and experienced project managers.

Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.

Press

24Feb 2021

Extensive analysis of medicine shortages in collaboration with LIF

 

The unavailability of medicines can be both problematic and lead to severe consequences for patients in need of therapy. However, in many cases other treatment alternatives can be provided. Quantify, in collaboration with Lif – de forskande läkemedelsföretagen, made several extensive analyses of medicine shortages during the last year. Here are some key takeaways:

– There were 437 shorted drug packages on the […]

22Feb 2021

Scientific impact of Quantify Research during 2020

At Quantify we are very proud of our research because of its positive impact on patients and the research community. Our CEO Kirk Geale proudly looks forward to our 2021 projects:

“We have such a great team at Quantify and I am continuously impressed by my colleagues’ contributions to the science that improves patients’ lives. Our collaborators play an equally important role – this work wouldn’t be possible without them. Quantify’s impact […]